| Original document(11 pages) 中文版 |
The invention relates to a pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process. |
Application Number
申请号 |
02149972 |
Application Date
申请日 |
2002.11.05 |
| Title 名称 |
Compsn. contg. 5-[4-[2-(N-methyl-N-2-pyridyl) amino-) oxethyl] beazyl] thiazolidine-2,4-tetraethyldiaminobenzophenone |
Publication Number
公开号 |
1430959 |
Publication Date
公开日 |
2003.07.23 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
A61K9/16;A61K31/4436;A61P3/10 |
Applicant(s) Name
申请人 |
Smithkline Beecham Ltd |
| Address 地址 |
|
| Inventor(s) Name 发明人 |
J. Paterl;H. Loss;R. Priss |
| Attorney & Agent 代理人 |
jiang jiancheng |
| More information 更 多 信 息 |
|
| Related patents information |
|
|
|
|
|
|